Cargando…

Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

One hundred large bowel carcinomas operated on between 1978 and 1982 were studied immunohistochemically with regard to expression of HLA-DR antigens. Three sections from each tumour were investigated by a semiquantitative scoring system, and a mean score for each patient established. Based on this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, S. N., Rognum, T. O., Lund, E., Meling, G. I., Hauge, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968312/ https://www.ncbi.nlm.nih.gov/pubmed/8318425

Ejemplares similares

Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis
por: Løvig, T, et al.
Publicado: (2002)

K-ras mutations and HLA-DR expression in large bowel adenomas.
por: Norheim Andersen, S., et al.
Publicado: (1996)

Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas?
por: Rognum, T. O., et al.
Publicado: (1983)

Expression of HLA-DR antigen in large bowel carcinoma.
por: Chang, E. S., et al.
Publicado: (1995)

Survival of large bowel carcinoma patients with different DNA ploidy.
por: Rognum, T. O., et al.
Publicado: (1987)

Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis.
por: Rognum, T. O., et al.
Publicado: (1987)

The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
por: Meling, G. I., et al.
Publicado: (1993)

The TP53 tumour suppressor gene in colorectal carcinomas. II. Relation to DNA ploidy pattern and clinicopathological variables.
por: Meling, G. I., et al.
Publicado: (1993)

Secretory component mRNA and protein expression in colorectal adenomas and carcinomas.
por: Krajci, P., et al.
Publicado: (1996)

Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.
por: Meling, G. I., et al.
Publicado: (1991)

Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma.
por: Rognum, T. O., et al.
Publicado: (1982)

Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis.
por: Meling, G. I., et al.
Publicado: (1991)

Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
por: Enz, Lukas Simon, et al.
Publicado: (2019)

HLA-DR Association in Papillary Thyroid Carcinoma
por: Amoli, Mahsa M., et al.
Publicado: (2010)

Effect of Selenium on HLA-DR Expression of Thyrocytes
por: Balázs, Csaba, et al.
Publicado: (2012)

High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma
por: Heng, Yu, et al.
Publicado: (2023)

HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules
por: Denzin, Lisa K., et al.
Publicado: (1996)

Association of HLA-DR1, HLA-DR13, and HLA-DR16 Polymorphisms with Systemic Lupus Erythematosus: A Meta-Analysis
por: Wang, Tingrui, et al.
Publicado: (2022)

K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location.
por: Breivik, J., et al.
Publicado: (1994)

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation
por: Ballou, Cassandra, et al.
Publicado: (2023)

HLA-DR expression, cytokines and bioactive lipids in sepsis
por: Das, Undurti
Publicado: (2014)

HLA-DR expression on monocytes is decreased in polytraumatized patients
por: Vester, Helen, et al.
Publicado: (2015)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

Dr. T. Saxty Good
Publicado: (1946)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
por: Xue, Ke, et al.
Publicado: (2018)

Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
por: Kleivi, Kristine, et al.
Publicado: (2007)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

HLA-DR Antigen Expression on the Thyrocytes of Graves’ Disease Patients
por: Lee, Myung Shik, et al.
Publicado: (1988)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma
por: Tichý, Michal, et al.
Publicado: (2019)

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis
por: Benevolo, Maria, et al.
Publicado: (2011)

HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma
por: Imani, Reza, et al.
Publicado: (2018)

Dr. Good's Study of Medicine
Publicado: (1823)

Dr. Maynard Gooding Burgess
Publicado: (1914)

Comparison of neutrophil CD64 and monocytic HLA-DR with existing biomarkers for the diagnosis and prognosis of sepsis
por: Pandey, Kshitij, et al.
Publicado: (2021)

T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP
Publicado: (1989)

Dr. Sylvester Emery Strong
Publicado: (1913)

Dr. Thomas D. Strong
Publicado: (1911)

Dr. Phineas H. Strong
Publicado: (1890)

HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.
por: Matsushita, K., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_d2n6s1d4vrhs20rdgbf4plcb2e